Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
Abstract Background The World Health Organization recommends regularly assessing the efficacy of artemisinin-based combination therapy (ACT), which is a critical tool in the fight against malaria. This study evaluated the efficacy of two artemisinin-based combinations recommended to treat uncomplica...
Main Authors: | Adama Gansané, Leah F. Moriarty, Didier Ménard, Isidore Yerbanga, Esperance Ouedraogo, Paul Sondo, Rene Kinda, Casimir Tarama, Edwige Soulama, Madou Tapsoba, David Kangoye, Cheick Said Compaore, Ousmane Badolo, Blami Dao, Samuel Tchwenko, Halidou Tinto, Innocent Valea |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-021-03585-6 |
Similar Items
-
A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
by: Souleymane Dama, et al.
Published: (2018-10-01) -
High therapeutic efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Somalia
by: Marian Warsame, et al.
Published: (2019-07-01) -
Bioequivalence study of dihydroartemisinin-piperaquine (DHP) generic formulation in fixed-dose combination, in healthy Indonesian volunteers
by: Ani Isnawati, et al.
Published: (2018-08-01) -
Formulation of Dihydroartemisinin-Piperaquine (DHP) Generic Tablet as Antimalarials Drug
by: Nanang Yunarto, et al.
Published: (2016-09-01) -
Choreoathetosis – an unusual adverse effect of dihydroartemisinin-piperaquine: a case report
by: Benjamin Momo Kadia, et al.
Published: (2017-12-01)